Skip to main content
Erschienen in: Abdominal Radiology 2/2014

01.04.2014

Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma

verfasst von: Tenyu Motoyama, Sadahisa Ogasawara, Tetsuhiro Chiba, Takashi Higashide, Hajime Yokota, Naoya Kanogawa, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Ryosuke Irie, Shigehiro Ochi, Yoshitada Masuda, Takashi Uno, Osamu Yokosuka

Erschienen in: Abdominal Radiology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

The purpose of the present study was to evaluate the usefulness of coronal reformatted images obtained from 64-slice multi-detector computed tomography to assess the ablative margin (AM) in hepatocellular carcinoma (HCC) treated with radio frequency ablation (RFA).

Methods

Ninety-five HCC nodules were analyzed in 66 HCC patients treated with RFA. Two radiologists and one hepatologist independently reviewed axial CT images with or without coronal reformatted images in HCC treated with RFA. Nodules were determined as AM-sufficient (≥5 mm) or AM-insufficient (<5 mm). The level of interobserver agreement was measured using the weighted kappa test. The sensitivity, specificity, and positive and negative predictive values (NPVs) of an insufficient AM (<5 mm) to predict local recurrence were evaluated.

Results

The numbers of AM-sufficient nodules judged by readers 1–3 based on axial images and both axial and coronal images were 56, 49, and 58, and 47, 33, and 48, respectively. Excellent agreement and good to excellent agreement were obtained among the three readers on axial image readings and both axial and coronal image readings, respectively. The mean sensitivity, specificity, and positive and NPVs of an insufficient AM on axial images and both axial and coronal images to predict local recurrence were 64%, 60%, 17%, and 93%, and 95%, 50%, 20%, and 97%, respectively.

Conclusions

Coronal reformatted CT images should be utilized to evaluate the AM in HCC treated with RFA in order to decrease the risk of local recurrence following treatment.
Literatur
1.
Zurück zum Zitat El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576PubMedCrossRef El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576PubMedCrossRef
2.
Zurück zum Zitat Cho YK, Kim JK, Kim MY, et al. (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:453–459PubMedCrossRef Cho YK, Kim JK, Kim MY, et al. (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:453–459PubMedCrossRef
3.
Zurück zum Zitat Garrean S, Hering J, Saied A, et al. (2008) Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195:508–520PubMedCrossRef Garrean S, Hering J, Saied A, et al. (2008) Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195:508–520PubMedCrossRef
4.
Zurück zum Zitat Park MH, Rhim H, Kim YS, et al. (2008) Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 28:379–390PubMedCrossRef Park MH, Rhim H, Kim YS, et al. (2008) Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 28:379–390PubMedCrossRef
5.
Zurück zum Zitat Barker DW, Zagoria RJ, Morton KA, et al. (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. AJR Am J Roentgenol 184:1096–1102PubMedCrossRef Barker DW, Zagoria RJ, Morton KA, et al. (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. AJR Am J Roentgenol 184:1096–1102PubMedCrossRef
6.
Zurück zum Zitat Schraml C, Clasen S, Schwenzer NF, et al. (2008) Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Abdom Imaging 33:643–651PubMedCrossRef Schraml C, Clasen S, Schwenzer NF, et al. (2008) Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases. Abdom Imaging 33:643–651PubMedCrossRef
7.
Zurück zum Zitat Yanaga Y, Awai K, Nakaura T, et al. (2008) Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. AJR Am J Roentgenol 190:1003–1009PubMedCrossRef Yanaga Y, Awai K, Nakaura T, et al. (2008) Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. AJR Am J Roentgenol 190:1003–1009PubMedCrossRef
8.
Zurück zum Zitat Marin D, Catalano C, De Filippis G, et al. (2009) Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT. AJR Am J Roentgenol 192:180–187PubMedCrossRef Marin D, Catalano C, De Filippis G, et al. (2009) Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT. AJR Am J Roentgenol 192:180–187PubMedCrossRef
9.
Zurück zum Zitat Bruix J, Sherman M (2011) American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022PubMedCentralPubMedCrossRef Bruix J, Sherman M (2011) American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Tateishi R, Shiina S, Teratani T, et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209PubMedCrossRef Tateishi R, Shiina S, Teratani T, et al. (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209PubMedCrossRef
11.
Zurück zum Zitat Shiina S, Teratani T, Obi S, et al. (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130PubMedCrossRef Shiina S, Teratani T, Obi S, et al. (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130PubMedCrossRef
12.
Zurück zum Zitat Tokunaga S, Koda M, Matono T, et al. (2012) Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. Br J Radiol 85:745–752PubMedCentralPubMedCrossRef Tokunaga S, Koda M, Matono T, et al. (2012) Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT. Br J Radiol 85:745–752PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Inoue T, Kudo M, Hatanaka K, et al. (2013) Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology 84(Suppl 1):51–57PubMedCrossRef Inoue T, Kudo M, Hatanaka K, et al. (2013) Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology 84(Suppl 1):51–57PubMedCrossRef
14.
Zurück zum Zitat Tomonari A, Tsuji K, Yamazaki H, et al. (2013) Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma. Hepatol Res 43:728–734PubMedCrossRef Tomonari A, Tsuji K, Yamazaki H, et al. (2013) Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma. Hepatol Res 43:728–734PubMedCrossRef
15.
Zurück zum Zitat Kim KW, Lee JM, Klotz E, et al. (2011) Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol 196:W565–W572PubMedCrossRef Kim KW, Lee JM, Klotz E, et al. (2011) Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol 196:W565–W572PubMedCrossRef
16.
Zurück zum Zitat Koda M, Tokunaga S, Miyoshi K, et al. (2012) Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 81:2730–2736PubMedCrossRef Koda M, Tokunaga S, Miyoshi K, et al. (2012) Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 81:2730–2736PubMedCrossRef
17.
Zurück zum Zitat Lee EY, Zucker EJ, Tsai J, et al. (2011) Pulmonary MDCT angiography: value of multiplanar reformatted images in detecting pulmonary embolism in children. AJR Am J Roentgenol 197:1460–1465PubMedCrossRef Lee EY, Zucker EJ, Tsai J, et al. (2011) Pulmonary MDCT angiography: value of multiplanar reformatted images in detecting pulmonary embolism in children. AJR Am J Roentgenol 197:1460–1465PubMedCrossRef
18.
Zurück zum Zitat Tsili AC, Argyropoulou MI, Gousia A, et al. (2012) Renal cell carcinoma: value of multiphase MDCT with multiplanar reformations in the detection of pseudocapsule. AJR Am J Roentgenol 199:379–386PubMedCrossRef Tsili AC, Argyropoulou MI, Gousia A, et al. (2012) Renal cell carcinoma: value of multiphase MDCT with multiplanar reformations in the detection of pseudocapsule. AJR Am J Roentgenol 199:379–386PubMedCrossRef
Metadaten
Titel
Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma
verfasst von
Tenyu Motoyama
Sadahisa Ogasawara
Tetsuhiro Chiba
Takashi Higashide
Hajime Yokota
Naoya Kanogawa
Eiichiro Suzuki
Yoshihiko Ooka
Akinobu Tawada
Ryosuke Irie
Shigehiro Ochi
Yoshitada Masuda
Takashi Uno
Osamu Yokosuka
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 2/2014
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-013-0054-0

Weitere Artikel der Ausgabe 2/2014

Abdominal Radiology 2/2014 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.